GLP-1 medications ranked by price in 2026

GLP-1 medications ranked by price in 2026 split into three real cost tiers, and the split has almost nothing to do with the drug name on the label. Compounded semaglutide and compounded tirzepatide sit at the bottom of the price ladder, brand-name GLP-1s without insurance sit at the top, and everything in between depends on whether your plan approves the prescription for weight loss. This guide ranks six GLP-1 options by where they actually land on that ladder in 2026.

Why this matters

Most people searching for GLP-1 medications ranked by price expect one simple list. The reality is messier: the same active ingredient (semaglutide) can sit in the cheapest tier or the priciest tier depending on whether it comes from a compounding pharmacy or a manufacturer, and whether your insurer treats weight loss as a covered indication. A side-by-side weight loss injections comparison makes the differences between formulations clearer before you commit to a plan.

The compounding question matters more in 2026 than it did a few years ago, since manufacturer shortages of Wegovy, Zepbound, and Mounjaro have pushed more patients toward 503A and 503B compounding pharmacies that prepare semaglutide and tirzepatide to order. That shift is exactly why compounded options now anchor the low end of this ranking.

What determines a GLP-1 medication's price tier

• Pharmacy sourcing — manufacturer brand-name product versus an FDA-registered 503A/503B compounding pharmacy
• Dosing frequency and format — weekly injection, daily injection, or daily oral pill
• Insurance formulary status — approved for diabetes, approved for weight loss, or self-pay only
• Bundled medical supervision — whether physician visits, dose titration, and lab review are included or billed separately
• Supply reliability — brand-name GLP-1s have faced recurring manufacturer shortages since 2022
• Commitment length — most GLP-1 plans run on 3-month or ongoing subscription cycles, not one-time purchases

At a glance: GLP-1 medications ranked by price tier

Medication	Best For	Price Tier	Key Limitation
Compounded Semaglutide	Self-pay patients starting GLP-1 therapy	Lowest	Not FDA-approved as a standalone finished product
Compounded Tirzepatide	Patients wanting dual GIP/GLP-1 action without brand pricing	Low-Mid	Same compounding oversight requirement as compounded semaglutide
Brand-name Semaglutide (Ozempic/Wegovy)	Patients with insurance formulary coverage	Mid-High	Weight-loss coverage often needs prior authorization
Brand-name Tirzepatide (Mounjaro/Zepbound)	Patients whose plan covers Zepbound or Mounjaro specifically	High	Frequent manufacturer shortages since 2022
Oral Semaglutide (Rybelsus)	Needle-averse patients	High	Needs a far higher milligram dose than injectable semaglutide
Liraglutide (Saxenda)	Patients who prefer daily over weekly dosing	Mid	Daily injection burden; older mechanism, generally less potent

1. Compounded Semaglutide: best GLP-1 medication for the lowest price tier

Compounded semaglutide is the same GLP-1 receptor agonist found in Ozempic and Wegovy, prepared to order by a licensed 503A or 503B compounding pharmacy instead of purchased as a finished manufacturer product. It's dispensed through telehealth platforms after a provider reviews your history and approves a dose. VevaRX prescribes compounded Semaglutide through this exact model for patients paying out of pocket.

Compounded Semaglutide pros:

• Sits at the lowest GLP-1 medications price tier in 2026
• Not tied to Novo Nordisk's manufacturer supply chain, so shortages hit it less often
• Dose titration can be adjusted closely with a prescribing provider

Compounded Semaglutide cons:

• Not FDA-approved as a finished product; quality depends entirely on the compounding pharmacy's accreditation
• Some states restrict or regulate compounded GLP-1 sales more tightly than others

Best for: patients starting GLP-1 therapy without insurance coverage for weight loss. Verdict: Buy — for self-pay patients who want the lower entry tier, provided the pharmacy is properly licensed.

2. Compounded Tirzepatide: best GLP-1 medication for dual-action therapy at a lower tier

Compounded tirzepatide delivers the same dual GIP/GLP-1 receptor mechanism found in Mounjaro and Zepbound, prepared by a compounding pharmacy rather than purchased as the branded product. It's dosed weekly, same as the injectable brand-name version, and prescribed after a telehealth intake. VevaRX offers compounded Tirzepatide alongside compounded Semaglutide for patients who want the stronger dual-mechanism option without the brand-name price tier.

Compounded Tirzepatide pros:

• Lower price tier than brand-name Zepbound or Mounjaro
• Dual GIP/GLP-1 mechanism, generally associated with stronger average results than semaglutide alone
• Weekly dosing schedule, same convenience as the brand-name version

Compounded Tirzepatide cons:

• Carries the same compounding oversight caveat as compounded semaglutide
• Newer to the market than compounded semaglutide, so fewer pharmacies have scaled production

Best for: patients who want tirzepatide's dual mechanism without paying full brand-name rates. Verdict: Buy — the lower tier makes sense if you've confirmed the pharmacy is licensed and physician-supervised.

3. Brand-name Semaglutide (Ozempic/Wegovy): best GLP-1 for insurance-covered patients

Ozempic was FDA-approved in 2017 for type 2 diabetes; Wegovy followed in 2021, approved specifically for chronic weight management, both built on the same active ingredient at different maximum doses (Ozempic tops out near 2mg weekly, Wegovy near 2.4mg weekly). A full online semaglutide providers comparison breaks down how different telehealth platforms handle brand-name prescribing.

Brand-name Semaglutide pros:

• Manufacturer quality control and long-established safety data going back to 2017
• Insurance or manufacturer savings programs can lower the effective price tier when approved
• Widely recognized by pharmacies and providers nationwide

Brand-name Semaglutide cons:

• Sits in the mid-to-high price tier without insurance approval
• Weight-loss coverage specifically often requires prior authorization, unlike diabetes coverage for Ozempic
• Recurring supply shortages have affected both Ozempic and Wegovy since 2022

Best for: patients whose insurance plan already covers Ozempic or Wegovy for weight management. Verdict: Hold — confirm formulary approval first, since the price tier hinges entirely on that approval.

4. Brand-name Tirzepatide (Mounjaro/Zepbound): best GLP-1 for covered dual-action therapy

Tirzepatide launched as Mounjaro in 2022 for type 2 diabetes, then as Zepbound in 2023 for chronic weight management, with a maximum approved dose of 15mg weekly for either indication. It's the newest major GLP-1/GIP option and generally the priciest tier without insurance backing it.

Brand-name Tirzepatide pros:

• Dual GIP/GLP-1 mechanism associated with strong average weight-loss results in published trials
• Manufacturer savings programs sometimes offset the price tier for eligible patients
• Fully FDA-approved, with manufacturer-controlled quality standards

Brand-name Tirzepatide cons:

• Highest price tier on this list without insurance coverage
• Shortages have been frequent since Zepbound's 2023 approval
• Prior authorization is common even for patients with otherwise strong coverage

Best for: patients with a health plan that specifically covers Zepbound or Mounjaro. Verdict: Hold — check your plan's formulary before assuming this tier applies to you.

5. Oral Semaglutide (Rybelsus): best GLP-1 for needle-averse patients

Rybelsus uses the same active ingredient as Ozempic and Wegovy but as a daily pill, FDA-approved in 2019. Because oral semaglutide absorbs poorly through the gut, the approved dose range runs from 7mg to 14mg daily — dramatically higher than the 0.25mg to 2.4mg weekly range used in injectable formulations.

Oral Semaglutide pros:

• No injections required, ever
• Same manufacturer quality standards as the injectable brand-name versions
• Established since 2019 with a solid safety track record

Oral Semaglutide cons:

• Sits in a higher price tier than injectable options despite the pill format
• Must be taken fasting with minimal water for absorption to work at all
• Generally associated with less weight loss than weekly injectable semaglutide or tirzepatide

Best for: patients who will not tolerate injections under any circumstance. Verdict: Wait — the dosing hassle and higher price tier make injectable compounded options the better first move for most patients.

6. Liraglutide (Saxenda): best GLP-1 for daily dosing preference

Saxenda was FDA-approved in 2014, making it one of the earliest GLP-1 receptor agonists specifically approved for weight management, dosed once daily up to a maximum of 3.0mg. It predates the weekly semaglutide and tirzepatide options by several years.

Liraglutide pros:

• Longest real-world track record of any GLP-1 on this list
• Daily dosing gives finer day-to-day control for some patients
• Well-understood side effect profile after a decade of use

Liraglutide cons:

• Daily injections instead of weekly, which most patients find less convenient
• Generally produces less weight loss than weekly semaglutide or tirzepatide
• Mid-tier pricing without matching the results of newer options

Best for: patients who specifically want a once-daily option or don't respond well to weekly high-dose GLP-1s. Verdict: Skip unless daily dosing is a hard requirement — weekly options generally deliver more value per price tier in 2026.

How this ranking was built

Each medication was placed by three factors: whether it comes from a compounding pharmacy or a manufacturer, whether insurance realistically covers it for weight loss versus diabetes, and how dosing frequency and format (weekly injection, daily injection, or daily pill) affect the total commitment. Compounded options rank lowest because they bypass manufacturer supply-chain pricing. Brand-name injectables rank highest without insurance because that's where list pricing and shortages collide.

Which GLP-1 medication should you choose in 2026?

For most self-pay patients, compounded Semaglutide through a telehealth provider is the default pick for the lowest price tier in 2026. Patients who want tirzepatide's dual mechanism without the brand-name premium should look at compounded Tirzepatide next. If your insurance already covers Ozempic, Wegovy, Mounjaro, or Zepbound for weight loss, that coverage — not the drug itself — is what determines whether brand-name makes financial sense for you.

FAQ

One last thing

The detail most people miss when comparing GLP-1 medications ranked by price: Rybelsus needs a dose roughly 6 to 50 times higher in milligrams than injectable semaglutide just to work, because the gut destroys most of an oral dose before it absorbs. That's the real reason the "convenient pill" option lands in a higher price tier than the weekly injection it's supposed to replace — the math is baked into the dosing, not the marketing.

Related guides

• Online semaglutide providers compared
• Semaglutide cost per month without insurance